Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2019 |
| Outros Autores: | , , , , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
| Texto Completo: | https://www.arca.fiocruz.br/handle/icict/39932 |
Resumo: | Fundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Vice-Presidência de Pesquisa e Coleções Biológicas. Rio de Janeiro, RJ, Brasil / Liver-pool School of Tropical Medicine, Liverpool, UK. |
| id |
CRUZ_f6b2e4227847af80361a5dfb07a89be6 |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/39932 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Daher, AndréAljayyoussi, GhaitPereira, Dhelio BatistaLacerda, Marcus V. G.Alexandre, Márcia A. A.Nascimento, Cristiana T.Alves, Júlio CastroFonseca, Laís Bastos daSilva, Diego Medeiros Dias daPinto, Douglas PereiraRodrigues, Danielle FonsecaSilvino, Ana Carolina RiosSousa, Taís Nóbrega deBrito, Cristiana Ferreira Alves deKuile, Feiko O. terLalloo, David G.2020-02-13T17:04:18Z2020-02-13T17:04:18Z2019DAHER, Andre et al. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine. Malaria Journal, v. 18, p. 1-9, 2019.1475-2875https://www.arca.fiocruz.br/handle/icict/3993210.1186/s12936-019-2950-4engBMC (part of Springer Nature)Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquineinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Vice-Presidência de Pesquisa e Coleções Biológicas. Rio de Janeiro, RJ, Brasil / Liver-pool School of Tropical Medicine, Liverpool, UK.Liver-pool School of Tropical Medicine, Liverpool, UK.Tropical Medicine Research Center of Rondonia (CEPEM). Porto Velho, RO, Brazil / Universidade Federal de Rondonia. Porto Velho, RO, Brazil.Fundação Oswaldo Cruz. Instituto Leônidas & Maria Deane. Manaus, AM, Brazil / Fundação de Medicina Tropical Medicine Dr. Heitor Vieira Dourado. Manaus, AM, Brazil.Fundação de Medicina Tropical Medicine Dr. Heitor Vieira Dourado. Manaus, AM, Brazil.Fundação de Medicina Tropical Medicine Dr. Heitor Vieira Dourado. Manaus, AM, Brazil.Fundação Oswaldo Cruz. Instituto Nacional de Doenças Infecciosas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Presidência. Vice-Presidência de Produção e Inovação em Saúde. Laboratório de Farmacocinética. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Presidência. Vice-Presidência de Produção e Inovação em Saúde. Laboratório de Farmacocinética. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Presidência. Vice-Presidência de Produção e Inovação em Saúde. Laboratório de Farmacocinética. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou, Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou, Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou, Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou, Belo Horizonte, MG, Brasil.Liver-pool School of Tropical Medicine, Liverpool, UK.Liver-pool School of Tropical Medicine, Liverpool, UK.Background: Activation of hypnozoites of vivax malaria causes multiple clinical relapses, which contribute to the Plasmodium vivax burden and continuing transmission. Artemisinin-based combination therapy (ACT) is effective against blood-stage P. vivax but requires co-administration with primaquine to achieve radical cure. The therapeutic efficacy of primaquine depends on the generation of a therapeutically active metabolite via cytochrome P450 2D6 (CYP2D6). Impaired CYP2D6 metabolism has been associated with primaquine treatment failure. This study investigated the association between impaired CYP2D6 genotypes, drug-exposure to the long-acting ACT component (schizonticidal drugs) and tolerance and efficacy. Methods: Adult patients with acute vivax malaria were enrolled in a recently completed trial and treated with artesunate–mefloquine, chloroquine or artemether–lumefantrine. All received concomitant primaquine (0.5 mg/kg/day for 7–9 days). The association between efficacy and safety and drug exposure was explored using area-under-the-curve (AUC) and half-life (t1/2) estimates obtained by non-compartmental analysis of the long half-life drugs. Parasite recurrences by day 63 were categorized as related relapses or re-infections/unrelated hypnozoite activation by genotyping three microsatellite loci and two polymorphic loci of merozoite surface antigen-1. The CYP2D6 genotype was identified with Taqman assays by real-time PCR to 9 polymorphisms (8 SNPs and one deletion). Impaired CYP2D6 activity was inferred using the Activity Score System. Results: Most recurrences in the ASMQ (67%), CQ (80%) and AL (85%) groups were considered related relapses. Eight of nine (88.9%) of the patients with impaired CYP2D6 activity relapsed with related parasite compared to 18/25 (72%) with normal activity (RR = 1.23, 0.88; 1.72, p = 0.40). There were no associations between the measured PK parameters and recurrence. Patients with longer chloroquine half-lives had more pruritus (RR = 1.09, 1.03; 1.14, p = 0.001). Higher CQ AUCs were associated with reduced falls in haemoglobin by day 14 (Coef − 0.02, − 0.005; − 0.03, p = 0.01). All regimens were well tolerated. Conclusion: Genotyping of P. vivax showed that activation of related (homologous) hypnozoites was the most frequent cause of recurrence. The high proportion of the impaired CYP2D6 activity among patients with recurrent infections suggests that slow primaquine metabolism might influence related relapse rates in Brazil among patients receiving primaquine for radical cure, although confirmatory studies are needed. There was no association between drug exposure of the long-acting ACT component (schizonticidal drugs) and risk of related relapse. ACT was well tolerated. These results provide further re-assuranceabout the safety and efficacy of ACT when combined with short course primaquine to treat uncomplicated malaria vivax in Brazil.MalariaPlasmodium vivaxAnti-malarial treatmentChloroquineMefloquineLumefantrinePrimaquineArtemisinin-based combination therapyACTPharmacokineticsClinical trialinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83082https://www.arca.fiocruz.br/bitstream/icict/39932/1/license.txt9193a7c197bc67acd023525e72a03240MD51ORIGINALPharmacokinetics.pdfPharmacokinetics.pdfapplication/pdf4762495https://www.arca.fiocruz.br/bitstream/icict/39932/2/Pharmacokinetics.pdfbf79584ac633b8db094ea9acfd3ce854MD52TEXTPharmacokinetics.pdf.txtPharmacokinetics.pdf.txtExtracted texttext/plain9https://www.arca.fiocruz.br/bitstream/icict/39932/3/Pharmacokinetics.pdf.txt33f4f15a16a9843faf6a25d4f387b6fdMD53icict/399322020-02-17 14:17:03.76oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352020-02-17T17:17:03Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.pt_BR.fl_str_mv |
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine |
| title |
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine |
| spellingShingle |
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine Daher, André Malaria Plasmodium vivax Anti-malarial treatment Chloroquine Mefloquine Lumefantrine Primaquine Artemisinin-based combination therapy ACT Pharmacokinetics Clinical trial |
| title_short |
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine |
| title_full |
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine |
| title_fullStr |
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine |
| title_full_unstemmed |
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine |
| title_sort |
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine |
| author |
Daher, André |
| author_facet |
Daher, André Aljayyoussi, Ghait Pereira, Dhelio Batista Lacerda, Marcus V. G. Alexandre, Márcia A. A. Nascimento, Cristiana T. Alves, Júlio Castro Fonseca, Laís Bastos da Silva, Diego Medeiros Dias da Pinto, Douglas Pereira Rodrigues, Danielle Fonseca Silvino, Ana Carolina Rios Sousa, Taís Nóbrega de Brito, Cristiana Ferreira Alves de Kuile, Feiko O. ter Lalloo, David G. |
| author_role |
author |
| author2 |
Aljayyoussi, Ghait Pereira, Dhelio Batista Lacerda, Marcus V. G. Alexandre, Márcia A. A. Nascimento, Cristiana T. Alves, Júlio Castro Fonseca, Laís Bastos da Silva, Diego Medeiros Dias da Pinto, Douglas Pereira Rodrigues, Danielle Fonseca Silvino, Ana Carolina Rios Sousa, Taís Nóbrega de Brito, Cristiana Ferreira Alves de Kuile, Feiko O. ter Lalloo, David G. |
| author2_role |
author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Daher, André Aljayyoussi, Ghait Pereira, Dhelio Batista Lacerda, Marcus V. G. Alexandre, Márcia A. A. Nascimento, Cristiana T. Alves, Júlio Castro Fonseca, Laís Bastos da Silva, Diego Medeiros Dias da Pinto, Douglas Pereira Rodrigues, Danielle Fonseca Silvino, Ana Carolina Rios Sousa, Taís Nóbrega de Brito, Cristiana Ferreira Alves de Kuile, Feiko O. ter Lalloo, David G. |
| dc.subject.en.pt_BR.fl_str_mv |
Malaria Plasmodium vivax Anti-malarial treatment Chloroquine Mefloquine Lumefantrine Primaquine Artemisinin-based combination therapy ACT Pharmacokinetics Clinical trial |
| topic |
Malaria Plasmodium vivax Anti-malarial treatment Chloroquine Mefloquine Lumefantrine Primaquine Artemisinin-based combination therapy ACT Pharmacokinetics Clinical trial |
| description |
Fundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Vice-Presidência de Pesquisa e Coleções Biológicas. Rio de Janeiro, RJ, Brasil / Liver-pool School of Tropical Medicine, Liverpool, UK. |
| publishDate |
2019 |
| dc.date.issued.fl_str_mv |
2019 |
| dc.date.accessioned.fl_str_mv |
2020-02-13T17:04:18Z |
| dc.date.available.fl_str_mv |
2020-02-13T17:04:18Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
DAHER, Andre et al. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine. Malaria Journal, v. 18, p. 1-9, 2019. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/39932 |
| dc.identifier.issn.pt_BR.fl_str_mv |
1475-2875 |
| dc.identifier.doi.none.fl_str_mv |
10.1186/s12936-019-2950-4 |
| identifier_str_mv |
DAHER, Andre et al. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine. Malaria Journal, v. 18, p. 1-9, 2019. 1475-2875 10.1186/s12936-019-2950-4 |
| url |
https://www.arca.fiocruz.br/handle/icict/39932 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
BMC (part of Springer Nature) |
| publisher.none.fl_str_mv |
BMC (part of Springer Nature) |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/39932/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/39932/2/Pharmacokinetics.pdf https://www.arca.fiocruz.br/bitstream/icict/39932/3/Pharmacokinetics.pdf.txt |
| bitstream.checksum.fl_str_mv |
9193a7c197bc67acd023525e72a03240 bf79584ac633b8db094ea9acfd3ce854 33f4f15a16a9843faf6a25d4f387b6fd |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1813008965601067008 |